trb_welcome.jpg

 

The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.


New VISMED® MULTI receives an award !

v_multi_award.jpg

TRB Chemedica has received an award for VISMED® MULTI from the aerosol and dispensing system experts in the category “Packaging Innovation, Functionality, Environment friendly” at the Aerosol & Dispensing Forum 2012 in Paris on February 8th & 9th 2012. The Paris Aerosol & Dispensing Awards ceremony highlighted the key role of dispensing technologies in the success of new products.

VISMED® MULTI eye lubricant consists of a preservative-free multidose dispenser that sterile filters the air entering the container. This system guarantees an in-use shelf life of 3 months after first use.


Ostenil-tendon_petit.jpg

NEW ! An Innovative Approach in the Treatment of Painful Tendinopathy

OSTENIL® TENDON was developed to treat pain and restricted mobility in tendon disorders. It is a conservative treatment based on the biomechanical properties of hyaluronic acid.

OSTENIL® TENDON is injected into the tendon sheath (intrasheath injection) or around the affected tendon (peritendinous injection) once a week for a total of 2 injections.

OSTENIL® TENDON provides rapid symptom relief in painful tendinopathy

Pack_Ostenil_Tendon petit.jpgpdf OSTENIL® Tendon instructions for use
pdf OSTENIL® Tendon brochure
Distributors
trb_contact.gif Contacts

News-Events
 
 
  • English